Abrupt discontinuation can worsen angina and has been associated with myocardial infarction and ventricular arrhythmias; the label advises avoiding abrupt withdrawal, including caution when treating hypertension with unrecognized coronary disease.
Warnings
Contraindicated in sinus bradycardia, >1st-degree block; Contraindicated in cardiogenic shock / overt failure
Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.
Label date: 20260825 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
Mechanism: Beta-1 selective (cardioselective) adrenergic receptor blocker without intrinsic sympathomimetic activity; blocks beta-2 at higher levels.
On both cards: Common side effects — Dizziness; Bradycardia; Depression
Only on the Metoprolol card: Used for — Hypertension in adults; Long-term angina pectoris treatment to reduce attacks and improve exercise tolerance; Reduction of cardiovascular mortality in hemodynamically stable patients with definite or suspected acute myocardial infarction · Common side effects — Tiredness; Shortness of breath · Warnings — Abrupt cessation may worsen ischemia; Worsening heart failure; May mask hypoglycemia · Interactions — Catecholamine-depleting drugs; CYP2D6 inhibitors; Digoxin, clonidine, diltiazem, verapamil
Mechanism: Racemic mixture: nonselective beta-blockade from the S(-) enantiomer and alpha-1 blockade from both enantiomers; no intrinsic sympathomimetic activity.
On both cards: Common side effects — Dizziness; Bradycardia
Only on the Carvedilol card: Used for — Mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually with other heart-failure medicines; Reduction of cardiovascular mortality in clinically stable survivors of acute myocardial infarction with LVEF at or below 40%; Essential hypertension · Common side effects — Fatigue; Hypotension; Hyperglycemia · Warnings — Do not abruptly discontinue; Bronchial asthma / bronchospastic conditions; May mask hypoglycemia · Interactions — CYP2D6 inhibitors, rifampin; Digoxin, cyclosporine; Clonidine, reserpine, MAO inhibitors
Mechanism: Nonselective beta blockade generally reduces myocardial oxygen demand in angina. Its antihypertensive mechanism is not established; reduced cardiac output, renin release and sympathetic outflow may contribute.
On both cards: Common side effects — Bradycardia · Warnings — Contraindicated in sinus bradycardia, >1st-degree block
Only on the Propranolol card: Used for — Hypertension and angina pectoris; Ventricular-rate control in atrial fibrillation with a rapid ventricular response; Reduction of cardiovascular mortality after the acute phase of myocardial infarction in clinically stable patients; Migraine prophylaxis and essential tremor · Common side effects — Fatigue / lassitude; Light-headedness; Nausea / vomiting; Vivid dreams · Warnings — Contraindicated in cardiogenic shock; Contraindicated in bronchial asthma; Abrupt discontinuation can worsen angina or precipitate myocardial infarction; the label calls for gradual withdrawal under medical supervision · Interactions — CYP2D6 / 1A2 / 2C19 inhibitors; Enzyme inducers (rifampin, phenytoin); Antiarrhythmics (propafenone)
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.
Capsera